MINERALYS THERAPEUTICS, INC. (MLYS) Operating cash flow 2022–2025
MINERALYS THERAPEUTICS, INC. (MLYS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$142.4MFY2025 · since FY2022: -$29.2M → -$142.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$142.4M | +14.4% |
| FY2024 | -$166.3M | -104.9% |
| FY2023 | -$81.2M | -177.8% |
| FY2022 | -$29.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MLYS financial trends
MLYS RevenueMLYS Net incomeMLYS Net marginMLYS Gross profitMLYS Gross marginMLYS Operating incomeMLYS Operating marginMLYS Free cash flowMLYS Capital expendituresMLYS Return on equityMLYS Stock buybacksMLYS Dividends paidMLYS Total assetsMLYS Total liabilitiesMLYS Shareholders’ equityMLYS overview →